Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease

J Neurol Sci. 2016 Mar 15:362:283-6. doi: 10.1016/j.jns.2016.02.004. Epub 2016 Feb 3.

Abstract

Frontotemporal Dementia (FTD) and Alzheimer's Disease (AD) share the accumulation of fibrillar aggregates of misfolded proteins. To better understand these neurodegenerative diseases and identify biomarkers in easily accessible cells, we investigated DNA methylation at Pin1 gene promoter and its expression in peripheral blood mononuclear cells of FTD patients. We found a lower gene expression of Pin1 with a higher DNA methylation in three CpG sites at Pin1 gene promoter analysed in FTD subjects, in contrast to a higher gene expression with a lower methylation in AD subjects and controls. These data suggest an important and distinct involvement of Pin1 in these two types of dementia.

Keywords: Alzheimer's disease; Frontotemporal dementia; Methylation; Neurodegeneration; Peripheral marker; Pin1.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / genetics*
  • Amyloid beta-Peptides / metabolism
  • DNA Methylation / genetics*
  • Female
  • Frontotemporal Dementia / diagnosis
  • Frontotemporal Dementia / genetics*
  • Gene Expression / genetics*
  • Humans
  • Male
  • Mental Status Schedule
  • Middle Aged
  • NIMA-Interacting Peptidylprolyl Isomerase / genetics*
  • NIMA-Interacting Peptidylprolyl Isomerase / metabolism
  • Promoter Regions, Genetic / genetics*
  • RNA, Messenger / metabolism
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • NIMA-Interacting Peptidylprolyl Isomerase
  • RNA, Messenger
  • tau Proteins
  • PIN1 protein, human